Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Nio

Showing results (11-20 of 194) with videos related to

Pageof 20
Sort By:
The Journal of Urology|February 1, 1992
Modulation by cis-diamminedichloroplatinum (II) of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to peripheral blood lymphocytes and lymphokine activated killer cellsY Mizutani, Y Nio, O Yoshida
Nederlands Tijdschrift Voor Geneeskunde|February 6, 1993
[Abdominal typhus and paratyphoid fever in 2 academic hospitals: 1984-1990]W N Hustinx, Y Nio, P Speelman
Cancer Chemotherapy and Pharmacology|June 8, 2001
Heterogeneic distribution of thymidine phosphorylase between primary tumors and metastatic lesions of human pancreatic ductal carcinoma: implications for the efficacy of chemotherapy with 5-FU or its derivativesY Minari, Y Nio, N Hirahara, et al.
Nihon Geka Hokan. Archiv Fur Japanische Chirurgie|January 1, 1978
[Recurrence of gallstones after lithotomy (author's transl)]Y Nio, A Hajiro, H Kato, et al.
Anticancer Research|July 23, 1998
Anticancer chemosensitivity and growth rate of freshly separated human colorectal cancer cells assessed by in vitro DNA synthesis inhibition assayK Kawabata, Y Nio, M Imamura, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cellsY Nio, J Zighelboim, J Berek, et al.
Cancer|February 15, 1993
Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cellsY Mizutani, B Bonavida, Y Nio, et al.
British Journal of Cancer|October 4, 2006
Ten-year follow-up results of a randomised controlled study comparing level-I vs level-III axillary lymph node dissection for primary breast cancerH Kodama, Y Nio, C Iguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1996
[Application for therapeutic use of deuterium oxide (D2O) against human pancreatic cancer]H Omori, Y Nio, H Takeda, et al.
Nihon Geka Hokan. Archiv Fur Japanische Chirurgie|May 1, 1992
Improved survival in mice with diet-induced pancreatitis treated with new potent protease inhibitor, E-3123 and a broad spectrum antibiotic, cefmetazoleT Hirano, T Manabe, G Ohshio, et al.
Pageof 20

Showing results (11-20 of 194) with videos related to

Sort By:
Pageof 20
The Journal of Urology|February 1, 1992
Modulation by cis-diamminedichloroplatinum (II) of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to peripheral blood lymphocytes and lymphokine activated killer cellsY Mizutani, Y Nio, O Yoshida
Nederlands Tijdschrift Voor Geneeskunde|February 6, 1993
[Abdominal typhus and paratyphoid fever in 2 academic hospitals: 1984-1990]W N Hustinx, Y Nio, P Speelman
Cancer Chemotherapy and Pharmacology|June 8, 2001
Heterogeneic distribution of thymidine phosphorylase between primary tumors and metastatic lesions of human pancreatic ductal carcinoma: implications for the efficacy of chemotherapy with 5-FU or its derivativesY Minari, Y Nio, N Hirahara, et al.
Nihon Geka Hokan. Archiv Fur Japanische Chirurgie|January 1, 1978
[Recurrence of gallstones after lithotomy (author's transl)]Y Nio, A Hajiro, H Kato, et al.
Anticancer Research|July 23, 1998
Anticancer chemosensitivity and growth rate of freshly separated human colorectal cancer cells assessed by in vitro DNA synthesis inhibition assayK Kawabata, Y Nio, M Imamura, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cellsY Nio, J Zighelboim, J Berek, et al.
Cancer|February 15, 1993
Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cellsY Mizutani, B Bonavida, Y Nio, et al.
British Journal of Cancer|October 4, 2006
Ten-year follow-up results of a randomised controlled study comparing level-I vs level-III axillary lymph node dissection for primary breast cancerH Kodama, Y Nio, C Iguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1996
[Application for therapeutic use of deuterium oxide (D2O) against human pancreatic cancer]H Omori, Y Nio, H Takeda, et al.
Nihon Geka Hokan. Archiv Fur Japanische Chirurgie|May 1, 1992
Improved survival in mice with diet-induced pancreatitis treated with new potent protease inhibitor, E-3123 and a broad spectrum antibiotic, cefmetazoleT Hirano, T Manabe, G Ohshio, et al.
Pageof 20